Filing Flows › Organon (OGN) › Q4 2025
Organon (OGN) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 24, 2026
Organon (OGN) reported revenue of $1.5B for the fourth quarter 2025 (Q4 2025), -5% from a year earlier and -6% from the quarter before. Operating margin was -9.8%, net loss $205M (13.6% of revenue).
Organon, Q4 2025: revenue $1.5B (-5% year over year), operating margin -9.8%, net loss $205M, operating cash flow $141M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5B | -6% | -5% |
| Operating profit | −$148M | -161% | — |
| Net earnings | −$205M | -228% | — |
| Operating cash flow | $141M | -47% | -64% |
| Free cash flow | $96.0M | -56% | -71% |
What changed
Revenue was $1.5B in Q4 2025, down 5% year over year and down 6% from the previous quarter.
Gross margin was 49.2%, down 7.1 points from a year earlier. Operating costs exceeded revenue by $0.15B, an operating margin of -9.8%. Operating expenses grew 16% against a revenue fall of 5%. The fastest-growing cost line was Other operating costs (+119%). The quarter ended with a net loss of $0.20B, after a profit of $0.16B the previous quarter.
Operating cash flow was $0.14B (down 64% year over year). Non-cash charges added back $0.25B of depreciation and amortization and $0.01B of share-based compensation. Working capital and other items added $0.09B. Capital expenditures of $0.04B left free cash flow of $0.10B.
Questions
What was Organon's revenue in the fourth quarter 2025?
Organon (OGN) reported revenue of $1.5B for the fourth quarter 2025 (Q4 2025), -5% from a year earlier and -6% from the quarter before.
Was Organon profitable in the fourth quarter 2025?
Operating loss was $148M (-9.8% of revenue) and net loss $205M.
Source: Organon 10-K on SEC EDGAR.